Table 2.
Recurrence pattern
| Total (N = 492) | dHGP (N = 103) | Non-dHGP (N = 389) | p-value | |
|---|---|---|---|---|
| Intrahepatic only | 166 (34%) | 44 (43%) | 122 (31%) | 0.030* |
| Pulmonary only | 104 (21%) | 22 (21%) | 82 (21%) | 0.951 |
| One other location only | 70 (14%) | 17 (17%) | 53 (14%) | 0.457 |
| Local recurrence primary only | 15 (3%) | 3 (3%) | 12 (3%) | |
| Peritoneal only | 3 (1%) | 1 (1%) | 2 (1%) | |
| Distant lymph nodes only | 26 (5%) | 7 (7%) | 19 (5%) | |
| Other location only | 26 (5%) | 6 (6%) | 20 (5%) | |
| Two or more locations | 152 (31%) | 20 (19%) | 132 (34%) | 0.005* |
| Intrahepatic and pulmonary only | 49 (10%) | 10 (10%) | 39 (10%) | |
| Intrahepatic and 1 other only | 41 (8%) | 3 (3%) | 38 (10%) | |
| Pulmonary and 1 other only | 25 (5%) | 1 (1%) | 24 (6%) | |
| Peritoneal and 1 other only | 2 (1%) | 0 (0%) | 2 (1%) | |
| Multi organ (> 2) | 35 (7%) | 6 (6%) | 29 (8%) | |
| Treatment of recurrence with curative intent | 224 (46%) | 61 (59%) | 163 (42%) | 0.002* |
*Indicates significant p-value